1 Small-Cap Stock on Our Watchlist and 2 We Question
3 Reasons to Sell COLL and 1 Stock to Buy Instead
STOUGHTON, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report first quarter 2026 financial results before the market opens...
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
3 Cash-Producing Stocks Walking a Fine Line
STOUGHTON, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: 25th...
1 Value Stock on Our Buy List and 2 Facing Headwinds
GE HealthCare and Collegium Pharmaceutical Stocks Trade Down, What You Need To Know
2 Profitable Stocks to Consider Right Now and 1 We Question
Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)